Company intelligence / Profile preview

Blue Collective

Brooklyn, New York, United States

Ownership: Private
Development stage: Other

Overview

Blue Collective is an active US-based VC firm investing in early-stage (pre-Seed, Seed, pre-Series A) startups across a wide range of industries. While it has invested in life sciences and healthcare startups, the firm itself is not a biotech, pharma, or healthcare operating company. It is not a drug-developing, technology, platform, or therapeutic company. It provides financing (typically $200,000–$2,000,000), often at pre-Seed or Seed stages. Portfolio companies include some in healthcare, such as Zocdoc (health tech marketplace), but "Blue Collective" itself is not an operator in these fields.

Industry: Investors

Beyond the preview

Go deeper on Blue Collective.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue Collective.

Explore the full profile